Different Bupivacaine Volumes in Infiltration Between Popliteal Artery and Capsule of Knee Block

NCT05438992 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2024-04-29

No results posted yet for this study

Summary

comparing between three different volumes; 15, 20 \& 25 ml of 0.25% bupivacaine to determine the best volume of Infiltration Between Popliteal Artery and Capsule of Knee (IPACK) block following adductor canal block (ACB) with the best analgesia and least complications after total knee arthroplasty (TKA)

Conditions

  • Pain, Postoperative

Interventions

DRUG

Bupivacaine 0.25% Preservative-Free Injectable Solution

local anesthetic drug injection for postoperative pain

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Heba Omar, MD · associate professor of anesthesia and surgical ICU, faculty of medicine, Cairo university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-15
Primary Completion
2024-03-31
Completion
2024-04-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05438992 on ClinicalTrials.gov